Smoking boosts fatty liver risk even in lean, light-drinking young adults: study Korea Biomedical Review 2d
NASA’s Juno probe has seen inside the Solar System’s most volcanic world, and it's pretty hellish in there IFLScience 11h Jupiter NASA Space Exploration All sources
Diabetes drug could help repair damage in fatty liver disease Knowridge Science Report 4h Fatty liver Diabetes Health
OpenAI blamed a hacking event on its AI models going rogue. Here's what to know PBS Online 1d OpenAI Top AI Brands AI All sources
Three millennia ago, humans may have spoken thousands more languages than we have today, during a linguistic ‘golden age’ Smithsonian Magazine 1h History All sources
Study: GLP-1 drugs like Ozempic linked to higher hair loss risk Study Finds 1d Wegovy Tirzepatide Global Health All sources
Why Is Novo Nordisk Suing Eli Lilly, and What Does it Mean for Investors? The Motley Fool 6h Novo Nordisk Mounjaro Eli Lilly All sources
Lose weight, and the risk of seizure? One study says Wegovy can help diabetes patients. Korea JoongAng Daily 1d Diabetes Global Health Health All sources
Emcure broadens Poviztra's use for MASH after CDSCO nod for semaglutide The Business Standard 4d CDSCO Novo Nordisk India All sources
Health worker monitored for Ebola in London hospital after working in DRC Irish Examiner 2d Ebola DR Congo UK Health Article paywall
Over 1,000 deaths recorded in ebola outbreak in DRC, Uganda — WHO Channels Television 2d DR Congo WHO Ebola
Poor sleep increases the risk of brain disorders: Warning signs you should never ignore The Week (India) 3d Indian Entertainment India World
Novo Nordisk’s fight against Eli Lilly has gone legal: A top lawyer evaluates the case Sunday Business Post 1d Eli Lilly Pharma Business
Here's why Novo Nordisk (NVO) fell more than broader market Zacks 2d S&P 500 Stock Markets (World) Stock Market (US)
Novo's false ad suit against Eli Lilly ramps up GLP-1 rivalry Law360 3d Eli Lilly Pharma Amycretin Article paywall
Citi lifts Novo Nordisk target on strong GLP-1 pill launch Proactive Investors (US) 4d Ozempic Stock Markets (World) Stock Market
Lonza delivered strong H1 2026 performance across all business platforms and upgrades full-year 2026 margin outlook Manufacturing Chemist 11h
An FDA committee just voted in favor of peptides—despite the agency's opposition TIME 1d FDA Inflammatory Bowel Disease US
